Annexon, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$342,264
13 notices · 64,697 sh
Oct 2025 to Oct 2026
Reported ·
$313,428
10 sales · 13 buys · $12.3M bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 10 reported sales carry the 10b5-1 box.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-08-13WIGGANS THOMAS G, Former Director$10,596
2026-07-15WIGGANS THOMAS G, Former Director$12,630
2026-07-14WIGGANS THOMAS G, Former Director$5,605
2026-03-02Yednock Ted, EVP & CHIEF INNOVATION OFFICER$30,181
Form 4, 2026-03-04: sold 5,566 at $5.42 Form 4 ↗
2026-03-02ARTIS DEAN RICHARD, EVP & CHIEF SCIENTIFIC OFFICER$31,980
Form 4, 2026-03-04: sold 5,894 at $5.43 Form 4 ↗
2026-03-02Overdorf Michael, EVP & CHIEF BUSINESS OFFICER$23,530
Form 4, 2026-03-04: sold 4,339 at $5.42 Form 4 ↗
2026-03-02Dananberg Jamie, CHIEF MEDICAL OFFICER$31,579
Form 4, 2026-03-04: sold 5,820 at $5.43 Form 4 ↗
2026-03-02Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER$30,178
Form 4, 2026-03-04: sold 5,565 at $5.42 Form 4 ↗
2026-02-18Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER$40,119
Form 4, 2026-02-20: sold 7,851 at $5.11 Form 4 ↗
2026-02-18ARTIS DEAN RICHARD, EVP & CHIEF SCIENTIFIC OFFICER$26,990
Form 4, 2026-02-20: sold 5,290 at $5.10 Form 4 ↗
2026-02-18Yednock Ted, EVP & CHIEF INNOVATION OFFICER$40,122
Form 4, 2026-02-20: sold 7,857 at $5.11 Form 4 ↗
2026-02-18Overdorf Michael, EVP & CHIEF BUSINESS OFFICER$31,764
Form 4, 2026-02-20: sold 6,225 at $5.10 Form 4 ↗